Christine Gebski, See Remarks at REPLIGEN CORP (RGEN), sold 6,754 shares at $285.33 ($1.9M) on 2021-09-01, disclosed to the SEC on 2021-09-02.
Open-market sale of $1.9M RGEN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $285.33 | 3,377 | $964K | 50.0% |
| 2 | $285.33 | 3,377 | $964K | 50.0% |
| Total | $285.33 avg | 6,754 | $1.9M | 100% |
| Filing → |
| RGEN | SELL | 2021-05-18 | $153K | — | Filing → |
| RGEN | SELL | 2021-03-18 | $276K | — | Filing → |